Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2003
08/21/2003US20030157705 Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system
08/21/2003US20030157687 Comprises nucleotide sequences coding enzyme inhibitor (TIMP-4) for treatment of arthritis, cancer and scarring
08/21/2003US20030157682 Preparing preferential amino acid sequences in vitro; detecting restriction fragment length polymorphisms
08/21/2003US20030157669 Ansamitocins
08/21/2003US20030157667 Method for producing L-amino acids using bacteria belonging to the genus escherichia
08/21/2003US20030157660 Non-M, non-O HIV-1 strains, fragments and uses
08/21/2003US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003US20030157642 Bacillus genetically engineeered for improved expression of secretion factor G (SECG) and heterologous proteins
08/21/2003US20030157641 Polycistronic expression of antibodies
08/21/2003US20030157636 Methylotrophic bacterium for the production of recombinant proteins and other products
08/21/2003US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157628 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157624 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157623 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157621 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157620 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157619 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157617 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157616 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157614 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157613 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157612 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157611 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157610 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157609 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157608 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157607 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157606 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157605 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157604 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157603 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157602 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157601 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157599 Comprises nucleotide sequence coding prostaglandin E receptor (EP3) for diagnosis and treatment of atherosclerotic diseases; restriction fragment length polymorphisms
08/21/2003US20030157594 Cell-free extract and glycoprotein synthesis system
08/21/2003US20030157519 Energy transfer between chromogens; gene expression cassette; medical diagnosis
08/21/2003US20030157508 Genetic engineering; gene therapy
08/21/2003US20030157485 Forensic analysis; chromosome marking
08/21/2003US20030157482 Binding labeled antibody to protein; measurement; calibration
08/21/2003US20030157130 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157111 76A11 polypeptide and uses thereof
08/21/2003US20030157109 Antibodies directed to PDGFD and uses thereof
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157103 Human amine transporter antibodies
08/21/2003US20030157100 Monoclonal antibody inducing apoptosis
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030155434 Spray nozzle apparatus and method of use
08/21/2003CA2492097A1 Signal for packaging of influenza virus vectors
08/21/2003CA2482633A1 Oligomeric molecules and uses thereof
08/21/2003CA2482333A1 Human antibodies for therapy against vaccinia or smallpox
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476232A1 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003CA2475929A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003CA2475926A1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003CA2475177A1 Materials and methods for preparing dimeric growth factors
08/21/2003CA2474885A1 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003CA2474782A1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003CA2454008A1 Use of xylene monooxygenase for the oxidation of substituted polycyclic aromatic compounds
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336620A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
08/20/2003EP1336109A1 Kit and method for detecting the esm-1 protein
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP1335934A1 Gene encoding protein cluster i and the encoded protein
08/20/2003EP1335932A1 Isolation of lectins
08/20/2003EP1147213A4 Novel rgs-containing molecules and uses thereof
08/20/2003EP0817852B1 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
08/20/2003EP0721510B1 Anti-cancer gene therapy by modulation of immune or inflammatory response
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003EP0324789B1 Methods of regulating metabolic stability of proteins
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1436854A Production process of human horny cell growth factor-2
08/20/2003CN1436853A Production process of vascular endothelial cell inhibine
08/20/2003CN1436847A Chinese human thymosin-alpha source and its prepn
08/20/2003CN1436792A Tumor necrosis factor relative cell death inducing ligand extracellular region mutation polypeptide and its prepn and use
08/20/2003CN1436791A Antineoplastic vascular endothelial suppressor protein for treatment and its production process
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/20/2003CN1118572C G-CSF analogue compisition, and preparing process thereof
08/20/2003CN1118571C Active protein with thrombopoietin
08/20/2003CN1118569C (-)-strand RNA virus vector having autonomously replicating activity
08/19/2003US6608242 Production of silk-like proteins in plants
08/19/2003US6608238 Incorporation of a DNA sequence into the secretory cells of the mammary gland to alter the milk composition; solution comprising the retroviral particles is displaced upwards using a substance with a higher density
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608180 Nucleotide sequences coding preferential protein for use cancer treatment
08/19/2003US6608178 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
1 ... 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 ... 1125